Prognostic Value of Biomarkers in RCC

Robert Alter, MD opines on the current prognostic value of biomarkers for RCC and the need for additional data in the field.

Related Videos
Expert on RCC
Experts on RCC
Experts on RCC
Experts on RCC
Experts on RCC
Experts on RCC
Data demonstrate the feasibility of automated glomerular filtration rate prediction to decide between partial nephrectomy and radical nephrectomy in kidney cancer, according to an expert from the Cleveland Clinic.
Experts on RCC
Experts on RCC
Early phase trials investigating cellular therapies, bispecific antibodies, and antibody-drug conjugates for refractory kidney cancer may uncover strategies to overcome resistance mechanisms.
Related Content